KPNA5 and pancreatic neoplasm: Besides, a recent study indicates that KPNA5 is highly expressed in pancreatic cancer patients without gemcitabine resistance, and upregulation of KPNA5 increases the response of gemcitabine‐resistant PANC‐1 cells to gemcitabine [23].